Literature DB >> 8807459

Prognosis of diabetic patients post-MI: the role of ACE inhibitor treatment. GISSI-3 Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

G Zuanetti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8807459     DOI： 10.1016/1056-8727(96)00027-x

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN： 1056-8727            Impact factor:   2.852


× No keyword cloud information.
  3 in total

Review 1.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

Authors:  G F M Strippoli; C Bonifati; M Craig; S D Navaneethan; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 2.  Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.

Authors:  K L Goa; J A Balfour; G Zuanetti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 3.  Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.

Authors:  Giovanni F M Strippoli; Maria Craig; Jonathan J Deeks; Francesco Paolo Schena; Jonathan C Craig
Journal:  BMJ       Date:  2004-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.